Important milestone in the All-comEr Register OCT (AERO).
Mit dem Votum der federführenden Ethikkommission ist in Deutschland eine entscheidende Hürde genommen.
The intensive work over the last few months has paid off. Together with Prof. Dr. David M. Leistner, Director of the Clinic for Cardiology and Angiology at Frankfurt University Hospital and Scientific Director of the ILUMIEN-V - AERO STUDY, IHF GmbH has developed a study concept that has now been positively evaluated by the ethics committee.
ILUMIEN-V - AERO is an IIT (investigator initiated trial) financially supported by Abbott Vascular.
ILUMIEN-V - AERO is a prospective, non-interventional, international, multicenter observational study in which 2,000 patients are to be included at 25 trial centers, including in Germany. The inclusion of further study countries is in preparation.
The study will provide results to evaluate the current practice of OCT use in routine care and assess the impact of the MLD-MAX algorithm on real world PCI.
English 
German